Πλοήγηση ανά Συγγραφέα "Parharidou, A."
-
Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
Economopoulos, T.; Papageorgiou, E.; Stathakis, N.; Constantinidou, M.; Parharidou, A.; Kostourou, A.; Dervenoulas, J.; Raptis, S. (1996)In this prospective study, patients with 'high risk' primary MDS, namely RAEB or RAEBt, were treated with combination chemotherapy (CT) supported by GM-CSF. The induction CT consisted of idarubicin 6 mg/m2 days 1-3 and ...